PER 2.50% 8.2¢ percheron therapeutics limited

DMD Phase 2 Results in Q4 = Potential 5000% Gem, page-145

  1. 173 Posts.
    lightbulb Created with Sketch. 37
    this news from 3 weeks ago is in reality a significant positive one and looks like many people still didnt realize this .oh dear cant wait for the phase 2 data this one could be a pure goldmine .....

    https://www.asx.com.au/asxpdf/20190724/pdf/446v6fxnxjtbkp.pdf

    No Serious Adverse Events (SAE’s) have been reported to date. The Data Safety Monitoring Board have been periodically evaluating the safety related trial data and have on each occasion recommended continuation of the trial with no safety concerns
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 7.9¢ $16.80K 210.0K

Buyers (Bids)

No. Vol. Price($)
1 24999 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 31992 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.